Scaling Success: The Dynamics of Late-Stage Investment in Biotech

About this session

Late-stage investment is where biotech innovation meets the demands of commercialization and global impact. This panel brings together top investors, executives, and industry experts to explore the unique challenges and opportunities of funding biotech companies on the cusp of breakthrough success. From navigating regulatory hurdles to scaling operations and preparing for IPOs or acquisitions, discover how late-stage funding is shaping the trajectory of biotech’s most promising ventures.

Speakers

• SV

  Sukaina Virji

  Director & Head of Health · Camarco (APCO)

  Moderator

• 

  Zina Affas Besse

  Partner & Deputy Head of Healthcare Private Equity · BNP Paribas Asset Management

  Panelist

• HB

  Hubert Birner

  Managing Partner · TVM Capital

  Panelist

• 

  Magdalena Jonikas

  Partner · JEITO

  Panelist

• TL

  Tim Lohoff

  Principal · Forbion

  Panelist

• CM

  Cedric Moreau

  Partner · Sofinnova Partners

  Panelist